Med-Chemist : "Quintessential Medicinal Chemistry"
Sunday, May 1, 2011
Maxwell Biotech, Sequella enter license agreement to commercialize SQ109 for TB treatment
In continuation of my update on drug discovery on
TB
...
Maxwell Biotech, Sequella enter license agreement to commercialize SQ109 for TB treatment.....
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment